Daehan New Pharm ranked among the top searched stocks on four days within the past month.

As of 1:32 PM on the 22nd, Daehan New Pharm is trading at 11,950 KRW, down 2.45% from the previous day. This represents a 16.02% increase compared to May 28. Daehan New Pharm is known as a manufacturer and seller of pharmaceuticals for human and veterinary use.

Over the past five days, individual investors have net purchased 226,681 shares, while foreigners and institutions have net sold 188,735 shares and 19,571 shares, respectively.

On June 16, Daehan New Pharm became a market topic with news of 'Raloxifene's COVID-19 inhibitory effect,' causing a 19% rise.

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing